Entera Bio Ltd.
ENTX
$1.96
-$0.02-1.01%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -10.60M | -10.09M | -9.54M | -9.18M | -8.54M |
| Total Depreciation and Amortization | 37.00K | 41.00K | 46.00K | 48.00K | 51.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.65M | 2.71M | 2.57M | 2.32M | 1.78M |
| Change in Net Operating Assets | 1.26M | 980.00K | 112.00K | -1.16M | -638.00K |
| Cash from Operations | -6.66M | -6.36M | -6.82M | -7.97M | -7.34M |
| Capital Expenditure | -40.00K | -11.00K | -3.00K | -5.00K | -5.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -40.00K | -11.00K | -3.00K | -5.00K | -5.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 17.10M | 18.31M | 4.82M | 7.89M | 7.88M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -584.00K | -528.00K | -342.00K | -599.00K | -599.00K |
| Cash from Financing | 16.52M | 17.78M | 4.48M | 7.29M | 7.28M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 9.82M | 11.41M | -2.35M | -683.00K | -67.00K |